Quest PharmaTech Income Statement

Financials in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Selling, General & Admin	0.47	0.49	0.77	0.5	0.62
Research & Development	0.24	0.33	0.54	0.34	0.17
Total Operating Expenses	0.71	0.82	1.32	0.83	0.79
Operating Income	-0.71	-0.82	-1.32	-0.83	-0.79
Interest Income	2.69	-0.82	-0.54	-3.12	-57.77
Other Non-Operating Income (Expense)	3.02	-0.16	-1.17	-60.94	-26.48
Total Non-Operating Income (Expense)	5.71	-0.98	-1.7	-64.05	-84.25
Pretax Income	5	-1.8	-3.02	-64.89	-85.04
Net Income	5	-1.8	-3.02	-64.89	-85.04
Net Income to Common	5	-1.8	-3.02	-64.89	-85.04
Shares Outstanding (Basic)	169	169	169	168	168
Shares Outstanding (Diluted)	169	169	169	168	168
Shares Change (YoY)	-	-	0.44%	0.09%	0.27%
EPS (Basic)	0.03	-0.01	-0.02	-0.38	-0.51
EPS (Diluted)	0.03	-0.01	-0.02	-0.38	-0.51
Free Cash Flow	-0.19	-0.51	-0.34	-0.55	-0.17
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
EBITDA	-0.71	-0.82	-1.31	-0.82	-0.75
EBIT	-0.71	-0.82	-1.32	-0.83	-0.79